Product Information
EZETIMIBE 10 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0672 per EA under NDC 00591371330. Its NADAC has been published 473 times since Jul 12, 2017.
FDA first approved this application on Jun 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Ezetimibe market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591371330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
EZETIMIBEApproval Type
Generic (ANDA)
FDA Application
ANDA200831FDA Approved
6/12/2017
TE Code
AB
On Market Since
6/12/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE 10 MG TABLET has been published 473 times since Jul 12, 2017, and over the history we have for it it has declined 99.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0672 per EA |
|---|---|
| All-time high | $6.9413 (Aug 16, 2017) |
| All-time low | $0.0672 (Jul 22, 2026) |
| 52-week high | $0.0756 |
| 52-week low | $0.0672 |
| Median price | $0.1288 |
| Average price | $0.2668 |
| Largest weekly change | -88.2% (Sep 20, 2017) |
| Weeks tracked | 473 |
| Tracking since | Jul 12, 2017 |
1W
N/A
1M
0.0%
3M
-6.0%
6M
-8.8%
1Y
-10.9%
3Y
-16.5%
5Y
-54.5%
All
-99.0%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.0672 per EA (NDC 00591371330), effective Jul 29, 2026.
How has the price of EZETIMIBE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 99.0%. It has been tracked across 473 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?
Since Jul 12, 2017, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0672 (Jul 22, 2026) to a high of $6.9413 (Aug 16, 2017), with a median of $0.1288 per EA.
Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?
13 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EZETIMIBE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures EZETIMIBE 10 MG TABLET?
EZETIMIBE 10 MG TABLET (NDC 00591371330) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.